Display options
Cite
Nazipi S, Stødkilde-Jørgensen K, Scavenius C, et al. The Skin Bacterium Propionibacterium acnes Employs Two Variants of Hyaluronate Lyase with Distinct Properties. Microorganisms. 2017;5(3)doi: 10.3390/microorganisms5030057.
Nazipi, S., Stødkilde-Jørgensen, K., Scavenius, C., & Brüggemann, H. (2017). The Skin Bacterium Propionibacterium acnes Employs Two Variants of Hyaluronate Lyase with Distinct Properties. Microorganisms, 5(3), . https://doi.org/10.3390/microorganisms5030057
Nazipi, Seven, et al. "The Skin Bacterium Propionibacterium acnes Employs Two Variants of Hyaluronate Lyase with Distinct Properties." Microorganisms vol. 5,3 (2017). doi: https://doi.org/10.3390/microorganisms5030057
Nazipi S, Stødkilde-Jørgensen K, Scavenius C, Brüggemann H. The Skin Bacterium Propionibacterium acnes Employs Two Variants of Hyaluronate Lyase with Distinct Properties. Microorganisms. 2017 Sep 12;5(3). doi: 10.3390/microorganisms5030057. PMID: 28895889; PMCID: PMC5620648.
Copy Download .nbib Format: NLM
Share it on

Microorganisms. 2017 Sep 12;5(3). doi: 10.3390/microorganisms5030057.

The Skin Bacterium Propionibacterium acnes Employs Two Variants of Hyaluronate Lyase with Distinct Properties.

Microorganisms

Seven Nazipi, Kristian Stødkilde-Jørgensen, Carsten Scavenius, Holger Brüggemann

Affiliations

  1. Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark. [email protected].
  2. Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark. [email protected].
  3. Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark. [email protected].
  4. Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark. [email protected].

PMID: 28895889 PMCID: PMC5620648 DOI: 10.3390/microorganisms5030057

Abstract

Hyaluronic acid (HA) and other glycosaminoglycans are extracellular matrix components in the human epidermis and dermis. One of the most prevalent skin microorganisms,

Keywords: Propionibacterium acnes; extracellular matrix; glycosaminoglycan; hyaluronate lyase; hyaluronic acid; skin microbiota

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Cytokine. 2014 Dec;70(2):97-103 - PubMed
  2. Int J Syst Evol Microbiol. 2016 Nov;66(11):4422-4432 - PubMed
  3. Int J Syst Evol Microbiol. 2015 Dec;65(12):4776-87 - PubMed
  4. Expert Rev Anti Infect Ther. 2011 Dec;9(12):1149-56 - PubMed
  5. Front Immunol. 2014 Mar 11;5:101 - PubMed
  6. Science. 2004 Jul 30;305(5684):671-3 - PubMed
  7. Nature. 2014 Oct 2;514(7520):59-64 - PubMed
  8. J Biol Chem. 2014 Sep 26;289(39):26914-21 - PubMed
  9. Methods Mol Biol. 2007;408:93-108 - PubMed
  10. Front Immunol. 2015 Apr 21;6:182 - PubMed
  11. J Immunol. 2006 Jul 15;177(2):1272-81 - PubMed
  12. Appl Microbiol. 1968 Sep;16(9):1434-6 - PubMed
  13. PLoS One. 2010 Aug 19;5(8):e12277 - PubMed
  14. Clin Dermatol. 2010 Jan-Feb;28(1):2-7 - PubMed
  15. Anal Biochem. 2011 Oct 1;417(1):41-9 - PubMed
  16. J Immunol. 2008 Aug 1;181(3):2103-10 - PubMed
  17. FASEB J. 2006 Jan;20(1):9-22 - PubMed
  18. Biochim Biophys Acta. 1997 Feb 8;1337(2):217-26 - PubMed
  19. J Gen Microbiol. 1979 Dec;115(2):411-8 - PubMed
  20. Biomed Res Int. 2013;2013:530382 - PubMed
  21. J Clin Microbiol. 2005 Jan;43(1):326-34 - PubMed
  22. Infect Immun. 2006 Jan;74(1):40-8 - PubMed
  23. PLoS One. 2014 Aug 11;9(8):e104199 - PubMed
  24. J Intern Med. 1997 Jul;242(1):27-33 - PubMed
  25. Lancet. 2012 Jan 28;379(9813):361-72 - PubMed
  26. Chem Rev. 2006 Mar;106(3):818-39 - PubMed
  27. J Invest Dermatol. 1972 Feb;58(2):66-70 - PubMed
  28. Int J Bacteriol. 2015;2015:218918 - PubMed
  29. PLoS One. 2012;7(7):e41480 - PubMed
  30. Science. 1985 Jun 14;228(4705):1324-6 - PubMed
  31. J Microbiol Methods. 2010 Nov;83(2):211-6 - PubMed
  32. Sci Rep. 2016 Nov 02;6:36412 - PubMed
  33. Cell. 2016 May 5;165(4):854-66 - PubMed
  34. J Invest Dermatol. 2013 Sep;133(9):2152-60 - PubMed
  35. Physiol Rev. 2011 Jan;91(1):221-64 - PubMed
  36. Sci Rep. 2016 Feb 09;6:20662 - PubMed
  37. Infect Immun. 2012 Apr;80(4):1390-8 - PubMed
  38. Eur J Cell Biol. 2006 Aug;85(8):699-715 - PubMed
  39. Bioinformatics. 2009 Oct 15;25(20):2730-1 - PubMed
  40. Curr Opin Cell Biol. 2000 Oct;12(5):581-6 - PubMed
  41. Nature. 2010 Mar 11;464(7286):250-5 - PubMed
  42. BMC Microbiol. 2010 Aug 27;10:230 - PubMed
  43. Microbiology. 2011 Jul;157(Pt 7):1990-2003 - PubMed
  44. FEMS Microbiol Lett. 2000 Feb 15;183(2):201-7 - PubMed
  45. Infect Agent Cancer. 2016 Jun 09;11:26 - PubMed
  46. Glycobiology. 2016 Jun;26(6):553-9 - PubMed
  47. J Lab Clin Med. 1949 Jan;34(1):74-89 - PubMed
  48. Anal Biochem. 1994 Jun;219(2):278-87 - PubMed
  49. Sci Rep. 2016 Aug 24;6:31968 - PubMed
  50. J Biochem. 1980 Oct;88(4):1015-23 - PubMed
  51. J Biol Chem. 2006 Nov 17;281(46):34936-41 - PubMed
  52. Arch Biochem Biophys. 1994 Dec;315(2):431-7 - PubMed
  53. J Biol Chem. 2004 Apr 23;279(17):17079-84 - PubMed
  54. Biochem J. 1997 Oct 1;327 ( Pt 1):65-71 - PubMed
  55. PLoS One. 2013 Sep 13;8(9):e70897 - PubMed
  56. Int J Syst Evol Microbiol. 2016 Dec;66(12 ):5358-5365 - PubMed
  57. Exp Dermatol. 2009 Nov;18(11):962-8 - PubMed
  58. J Clin Invest. 1996 Nov 15;98(10):2403-13 - PubMed
  59. Prostate. 2013 May;73(7):770-7 - PubMed
  60. PLoS Genet. 2013 May;9(5):e1003495 - PubMed
  61. J Clin Microbiol. 2012 Apr;50(4):1158-65 - PubMed
  62. Eur J Microbiol Immunol (Bp). 2017 Feb 27;7(1):37-45 - PubMed
  63. Can J Microbiol. 1997 Apr;43(4):315-21 - PubMed
  64. Respir Investig. 2013 Jun;51(2):56-68 - PubMed

Publication Types